Pure Global

MaxLINE HIV 1 & 2 Tri-Line Rapid Test Serum/Plasma - FDA Registration d6bf3112444fb0d6e8421d95422982e7

Access comprehensive regulatory information for MaxLINE HIV 1 & 2 Tri-Line Rapid Test Serum/Plasma in the Myanmar medical device market through Pure Global AI's free database. This medical device is registered under FDA ID d6bf3112444fb0d6e8421d95422982e7 and manufactured by Avecon Healthcare Pvt. Ltd.. The device was registered on July 27, 2022.

This page provides complete registration details including manufacturer information, authorized representative details, and regulatory compliance data from the official Myanmar FDA medical device database. Pure Global AI offers free access to Myanmar's complete medical device registry.

Free Database
Powered by Pure Global AI
FDA Official Data
d6bf3112444fb0d6e8421d95422982e7
MaxLINE HIV 1 & 2 Tri-Line Rapid Test Serum/Plasma
FDA ID: d6bf3112444fb0d6e8421d95422982e7
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Brand Name
MaxLINE
Registration Information
Analysis ID
d6bf3112444fb0d6e8421d95422982e7
Registration Date
July 27, 2022